Medicare Enrolled

Dr. Ahmad Yehya, M.D.

Endocrinology · Houston, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
4126 SOUTHWEST FWY STE 1210, Houston, TX 77027
2817849223
Registered in NPPES since 2014
NPI: 1659780013 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Yehya from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yehya? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Yehya

Dr. Ahmad Yehya is an endocrinology specialist in Houston, TX, with 12 years of NPI registration. Based on federal Medicare data, Dr. Yehya performed 2,103 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Yehya received a total of $6,879 from 37 pharmaceutical and/or device companies across 359 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Yehya is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years of NPI registration ▲ Top 20% volume in TX $6,879 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
2,103
Medicare services
Top 20% in TX for endocrinology
Not available
Unique patients (not deduplicated)
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
884 $84 $190
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
511 $8 $24
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
373 $33 $379
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
205 $25 $112
Total calcium level test
A blood test that measures the total amount of calcium in your body.
50 $5 $20
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
32 $115 $265
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
27 $77 $247
Bone density scan (DEXA) of forearm, finger, hand, or foot
A DEXA scan measures bone mineral density in the forearm, finger, hand, or foot. This test helps assess bone strength and risk of fracture.
21 $28 $197
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,879
Total received (2018-2024)
Avg $983/year across 7 years
Top 40% in TX for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
359
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,259
2023
$1,337
2022
$1,621
2021
$454
2020
$672
2019
$170
2018
$366

Payments by company (2024)

Dexcom, Inc.
$485
Abbott Laboratories
$398
Novo Nordisk Inc
$201
Xeris Pharmaceuticals, Inc.
$178
CeQur Corporation
$166
Corcept Therapeutics
$153
Lilly USA, LLC
$149
Bayer Healthcare Pharmaceuticals Inc.
$133
Boehringer Ingelheim Pharmaceuticals, Inc.
$89
Radius Health, Inc.
$77
Tandem Diabetes Care, Inc.
$47
Amgen Inc.
$41
Neurocrine Biosciences, Inc.
$39
ABBVIE INC.
$32
Insulet Corporation
$26
Esperion Therapeutics, Inc.
$23
Kyowa Kirin, Inc.
$19
Top 3 companies account for 48.0% of 2024 payments
All-time payments by company (2018-2024) ›
Dexcom, Inc.
$961
Abbott Laboratories
$680
Novo Nordisk Inc
$658
Lilly USA, LLC
$519
Boehringer Ingelheim Pharmaceuticals, Inc.
$517
SANOFI-AVENTIS U.S. LLC
$470
Amgen Inc.
$420
Xeris Pharmaceuticals, Inc.
$294
Radius Health, Inc.
$229
AstraZeneca Pharmaceuticals LP
$202
Corcept Therapeutics
$199
Bayer Healthcare Pharmaceuticals Inc.
$181
CeQur Corporation
$166
Medtronic MiniMed, Inc.
$160
AbbVie Inc.
$121
Medtronic, Inc.
$119
Valeritas, Inc.
$116
PFIZER INC.
$112
ABBVIE INC.
$99
LIFESCAN, INC.
$92
Merck Sharp & Dohme Corporation
$77
Tandem Diabetes Care, Inc.
$65
IBSA Pharma Inc.
$48
Amarin Pharma Inc.
$42
DEXCOM, INC.
$40
Neurocrine Biosciences, Inc.
$39
Merck Sharp & Dohme LLC
$36
GRT US Holding, Inc.
$29
LifeScan, Inc.
$27
Insulet Corporation
$26
Amneal Pharmaceuticals LLC
$26
Esperion Therapeutics, Inc.
$23
Kyowa Kirin, Inc.
$19
Becton, Dickinson and Company
$18
Horizon Therapeutics plc
$17
Bayer HealthCare Pharmaceuticals Inc.
$16
AbbVie, Inc.
$14
Top 3 companies account for 33.4% of all-time payments
Associated products mentioned in payments ›
BAQSIMI · BD Nano · CeQur Simplicity · Crysvita · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · EVENITY · FARXIGA · FREESTYLE LIBRE · FreeStyle Freedom Lite system · GVOKE HYPOPEN · GVOKE PFS · INTELLIS ADAPTIVESTIM · JANUVIA · JARDIANCE · Kerendia · Korlym · LICART · MINIMED 770G · MINIMED 780G · MOUNJARO · Minimed 630G · Minimed 670G System · Minimed 770G System · NEXLETOL · ONETOUCH VERIO REFLECT · Omnipod · OneTouch Verio Reflect · Ozempic · PREVNAR 20 · Qutenza · RECORLEV · Repatha · Rybelsus · SOLIQUA 100/33 · SOMAVERT · STEGLUJAN · SYNTHROID · Saxenda · Synthroid · TEPEZZA · TOUJEO · TRULICITY · Tirosint · Tymlos · UBRELVY · UNITHROID · V-GO · Vascepa · Wegovy · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an endocrinology specialist in Houston?
Compare endocrinologists in the Houston area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists in nearby ZIP areas
149
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
BEHAVIORAL HOSPITAL OF BELLAIRE
2.7 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Yehya is a clinical cardiology specialist, with above-average Medicare volume (top 20% in TX).

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Yehya experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Yehya performed 884 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Yehya receive payments from pharmaceutical companies?
Yes. Dr. Yehya received a total of $6,879 from 37 companies across 359 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yehya's costs compare to other endocrinologists in Houston?
Dr. Yehya's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yehya) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →